RegionInternational. Neutral scientific reference — not offered for sale here.
Cart · 0
Set region
Explore  /  Oxyresveratrol
Research reference — not for sale

Oxyresveratrol

C
lead outcome
Hyperpigmentation / brightening appearance…
grades vary by outcome ↓
Small molecule (non-peptide)
also called — Oxyresveratrol · trans-oxyresveratrol · mulberry stilbenoid (Morus alba) · INCI: Oxyresveratrol
skin appearance (cosmetic)hyperpigmentation appearance / brighteningantioxidant
In brief

Oxyresveratrol is a stilbene from mulberry (Morus alba) — a hydroxylated relative of resveratrol — with a standout property: it is a potent tyrosinase inhibitor, frequently cited as stronger than resveratrol itself and comparable to reference brighteners in the lab. That makes it a legitimate brightening antioxidant with a sound mechanism. The honest calibration is the usual one for a stilbene: controlled human topical trials are limited, so much of the case rests on potent in-vitro tyrosinase inhibition rather than large clinical data, and stability and penetration are the practical limits. As with every brightener here, it evens the look of existing pigment rather than lightening baseline skin.

Legal standing, by region
European Union
Lawful cosmetic ingredient

Oxyresveratrol (INCI) is a lawful cosmetic ingredient; claims must remain appearance-based.

International
Lawful cosmetic ingredient

Used as a brightening antioxidant stilbene, typically from mulberry (Morus alba). Rules vary by region.

Evidence, by outcome
How we grade →

An honest grade per outcome — drawn from the evidence, not any catalogue. Hype and undemonstrated marketing claims grade low.

OutcomeEvidence base · effectGrade
Hyperpigmentation / brightening appearance (topical)
Controlled human topical trials are limited; much of the case is potent in-vitro tyrosinase inhibition rather than large clinical data.
A stilbene (a hydroxylated relative of resveratrol) with a notably strong tyrosinase-inhibition profile and some topical/mechanistic support for reducing the appearance of pigmentation. · Softening of pigment appearance reported.
C
Tyrosinase inhibition / antioxidant (mechanism)
Grades the MECHANISM. Stability and penetration are the limiting factors, as with other stilbenes.
Well-described: oxyresveratrol is a potent tyrosinase inhibitor — often cited as stronger than resveratrol and comparable to reference brighteners in assays — and a polyphenol antioxidant. · Strong, consistent tyrosinase inhibition and antioxidant activity in the lab.
B
"Whitening" / skin-tone lightening
Endpoints concern the appearance of existing pigment, not a shift in baseline skin colour.
Marketing claim
D
Tolerability / formulation
Like other stilbenes, oxyresveratrol can be unstable and penetrate variably; formulation matters.
Cosmetic use; generally tolerated · Gentle profile
Disclosure

Vallydia sells its own cosmetic serums, and some ingredients graded here belong to the same categories as those products. Grades are drawn from the published evidence by the method we publish, and applied to our own ingredients on the same terms — our copper-peptide serum is graded no more kindly than the peptides it competes with. We disclose the interest so you can weigh it.

Trade names shown here (for example Matrixyl, Argireline, Syn-Ake) are the property of their respective owners and are used only to identify the ingredient under discussion. Their appearance implies no affiliation with, or endorsement by, the proprietor.

Evidence changes

Get notified if this changes

We track new research and update these grades as the evidence moves. Leave your email and we'll tell you if the evidence for Oxyresveratrol changes - nothing else.

One ingredient, one purpose. No marketing, no sharing. Unsubscribe anytime. See our privacy policy.

Cosmetic claims boundary
✓ Allowed (appearance / feel)
  • for the appearance of a brighter, more even complexion
  • helps reduce the look of dark spots
  • antioxidant support for the look of protected skin
✕ Not allowed (medicinal)
  • treats melasma
  • treats hyperpigmentation
  • cures dark spots
  • bleaches skin
  • inhibits tyrosinase
  • skin-whitening

The medicinal-sounding science stays in the reference section; product copy speaks only to appearance/feel (Reg 655/2013). Different fields, never merged.

The honest part

Oxyresveratrol is a cosmetic brightening antioxidant framed around the appearance of even tone. Its tyrosinase-inhibition mechanism is genuinely strong in the lab — often stronger than resveratrol — but controlled human topical evidence is limited, and stability and penetration are practical constraints. As with every brightener, it evens the look of existing pigment rather than lightening baseline skin, and persistent pigmentation such as melasma is a dermatologist's territory.

Identity

Oxyresveratrol is a stilbene — a polyphenol closely related to resveratrol, with an extra hydroxyl group — found notably in mulberry (Morus alba). In cosmetics it is used under the INCI name Oxyresveratrol as a brightening antioxidant. The extra hydroxyl is not a trivia point: it is a large part of why oxyresveratrol is a markedly stronger tyrosinase inhibitor than resveratrol, which is its main cosmetic distinction.

Mechanism (as proposed)

Oxyresveratrol works on pigment primarily by inhibiting tyrosinase, the rate-limiting enzyme of melanin synthesis — and it does so potently, often cited as stronger than resveratrol and comparable to reference brighteners in assays. It is also a polyphenol antioxidant. The mechanism is genuine and, for a stilbene, unusually strong on the pigment axis. The honest limiter is physical: like other stilbenes it can be unstable and penetrate variably, so how much of that lab potency reaches living skin depends on the formulation.

Reading the evidence honestly

The gap is clinical: controlled human topical trials are limited, so oxyresveratrol's case rests more on potent in-vitro tyrosinase inhibition than on large skin studies — which is exactly why the grade is C rather than higher, despite a strong mechanism. As with every brightener in this register, the measured endpoint is the appearance of existing pigment, not a lightening of baseline skin colour, and persistent or hormonal pigmentation such as melasma is a dermatologist's domain.

Scan your productSee if Oxyresveratrol is in what you're usingOpen the scanner →
Chemical identifiers

Cross-reference identifiers for the authoritative external databases — not a recipe, and nothing about how to use it.

PubChem CID5281717
InChIKeyPDHAOJSHSJQANO-OWOJBTEDSA-N

via PubChem CID 5281717 — InChIKey and formula (C14H12O4, one more O than resveratrol) verified. · verified confidence

Sources — 2 cited
01Mechanistic literature on oxyresveratrol tyrosinase inhibition (often compared favourably to resveratrol) and antioxidant activity.
02resolve:required — verify controlled human topical pigmentation citations before publishing; current case is mechanism-dominant.
Updated 2026-08-07

Grades reflect the published evidence, not our interest. No dosing, reconstitution, or administration is published for research compounds — that restraint is deliberate.

Related compounds
ResveratrolC
Small molecule (non-peptide)
Glabridin (Licorice)C
Small molecule (non-peptide)
Kojic AcidC
Small molecule (non-peptide)
Alpha ArbutinB
Small molecule (non-peptide)
Ellagic AcidC
Small molecule (non-peptide)
Explore by goal
Skin & aesthetic
Vallydia

A neutral reference and a lawful-lane shop. Information for those who seek it — never promotion.

RegionInternational
ExploreRegisterThe Register — full indexCategoriesTrust & COAHow we gradeOpen data
ShopCosmetic peptidesJournalQuizzes
TermsPrivacyCookiesReturnsShippingImprint

This site provides neutral scientific reference and sells only products lawful in your region. Nothing here is medical advice, a recommendation, or an offer to supply unapproved medicines. No dosing or administration is published for research compounds. Cosmetic peptides per Regulation (EC) 1223/2009. Unapproved injectable peptides are neither sold nor advertised in the EU (Directive 2001/83/EC, Title VIII). © 2026 Vallydia.